share_log

Titan Medical (TSE:TMD) Trading Up 7.1%

Titan Medical (TSE:TMD) Trading Up 7.1%

泰坦醫療 (TMD) 交易上漲 7.1%
Financial News Live ·  2023/02/02 15:31

Titan Medical Inc. (TSE:TMD – Get Rating)'s share price was up 7.1% during mid-day trading on Tuesday . The company traded as high as C$1.24 and last traded at C$1.20. Approximately 28,127 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 58,968 shares. The stock had previously closed at C$1.12.

泰坦醫療股份有限公司(TSE:TMD-獲取評級)的股價在周二中間交易期間上漲了 7.1%。該公司的交易價格高達 1.24 加元,最後交易價格為 1.20 加元。日間交易期間成交約 28,127 股股份,較每日平均成交量 58,968 股下跌 52%。該股票之前已收盤 1.12 加元。

Titan Medical Stock Performance

泰坦醫療股票表現

The business's fifty day moving average is C$1.01 and its 200-day moving average is C$0.77. The stock has a market capitalization of C$130.91 million and a PE ratio of -10.64. The company has a quick ratio of 1.18, a current ratio of 1.41 and a debt-to-equity ratio of 21.28.

該業務的五十天移動平均線為 1.01 加元,其 200 天移動平均線為 0.77 加元。該股的市值為 130.91 萬加元,私募股票的私募比率為 -10.64。該公司的快速比率為 1.18,流動比率為 1.41,債務與權益比率為 21.28。

Get
取得
Titan Medical
泰坦醫療
alerts:
警報:

Titan Medical (TSE:TMD – Get Rating) last released its earnings results on Thursday, November 10th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, analysts anticipate that Titan Medical Inc. will post -1.9800001 EPS for the current fiscal year.

泰坦醫療(TSE:TMD-獲取評級)上次公佈了 11 月 10 日(星期四)的盈利結果。該公司報告了該季度每股盈利(0.12 美元)。作為一個集團,分析師預計泰坦醫療股份有限公司將在本會計年度公佈 -1.9800001 每股盈餘。

Titan Medical Company Profile

泰坦醫療公司簡介

(Get Rating)
(取得評分)

Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.

Titan Medical Inc. 是一家醫療技術公司,專注於機器人輔助手術技術的開發和商業化,以應用於微創手術。它正在開發 Eos 系統,一種機器人單一進入手術系統,該系統包括一個外科手術控制的患者推車,該手術包括 3D 高清視覺系統和用於執行外科手術的多關節儀器;以及在外科手術期間為外科醫生提供符合人體工程學的接口,以及患者身體內的 3D 內窺鏡視圖。

See Also

另請參閱

  • Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
  • Mullen Automotive Stock Gains Momentum On Positive News
  • Harley-Davidson Inc. Stock, Is It Time To Buy?
  • The Bottom Is In For Meta Platforms, Volatility Is Not Over
  • Analyzing Alaska Air's Recent Earnings
  • 凱西·伍茲的方舟創新 ETF 將在 2023 年反彈?
  • 馬倫汽車股票在積極新聞中獲得動力
  • 哈雷戴維森公司股票,是時候購買了嗎?
  • 對於元平台來說,波動性還沒有結束
  • 分析阿拉斯加航空的近期盈利

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接收泰坦醫療日報的最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Titan Medical 和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論